Literature DB >> 23436312

Recent trends in cost-related medication nonadherence among stroke survivors in the United States.

Deborah A Levine1, Lewis B Morgenstern, Kenneth M Langa, John D Piette, Mary A M Rogers, Sudeep J Karve.   

Abstract

OBJECTIVE: Recent economic and health policy changes may have affected the ability of chronically ill patients to afford their medications. We assessed changes in cost-related nonadherence to medication (CRN) before and after the implementation of Medicare Part D in 2006.
METHODS: We used data from the National Health Interview Survey, an annual, population-based survey of community-dwelling, noninstitutionalized US adults, to estimate CRN in 8,673 stroke survivors aged 45 years or older, representing 4.8 million survivors, for the years 1999 to 2010. The main outcome measure was CRN, defined as self-reported inability to afford prescribed medication within the past 12 months.
RESULTS: During the period 1999 to 2010, 11.4% of stroke survivors, approximately 543,000 individuals, reported CRN. From 1999 to 2010, CRN more than doubled among stroke survivors aged 45 to 64 years (from 12.7 to 26.5%; ptrend = 0.01). CRN remained stable among those aged 65 years or older (from 3.8 to 7.0%; ptrend = 0.21). From 1999-2005 to 2006-2010, CRN among uninsured stroke survivors aged 45 to 64 years increased from 43.1 to 57.1% (p = 0.03). Among stroke survivors aged 65 years or older with Medicare coverage, CRN was higher among Medicare Part D participants than those without the drug benefit (7.9 vs 4.8%; p = 0.02). After adjustment for sociodemographic and clinical factors, CRN was similar among Medicare Part D enrollees and nonenrollees.
INTERPRETATION: From 1999 to 2010, CRN increased significantly among stroke survivors younger than 65 years, particularly among those without health insurance. There was no evidence that Medicare Part D decreased CRN among stroke survivors with Medicare.
Copyright © 2013 American Neurological Association.

Entities:  

Mesh:

Year:  2013        PMID: 23436312      PMCID: PMC3677727          DOI: 10.1002/ana.23823

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  44 in total

1.  Clopidogrel use and early outcomes among older patients receiving a drug-eluting coronary artery stent.

Authors:  Gregory A Roth; Nancy E Morden; Weiping Zhou; David J Malenka; Jonathan Skinner
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-12-06

2.  Medication characteristics beyond cost alone influence decisions to underuse pharmacotherapy in response to financial pressures.

Authors:  John D Piette; Michele Heisler; Todd H Wagner
Journal:  J Clin Epidemiol       Date:  2006-07       Impact factor: 6.437

3.  High-dose atorvastatin after stroke or transient ischemic attack.

Authors:  Pierre Amarenco; Julien Bogousslavsky; Alfred Callahan; Larry B Goldstein; Michael Hennerici; Amy E Rudolph; Henrik Sillesen; Lisa Simunovic; Michael Szarek; K M A Welch; Justin A Zivin
Journal:  N Engl J Med       Date:  2006-08-10       Impact factor: 91.245

4.  Financial barriers to health care and outcomes after acute myocardial infarction.

Authors:  Ali R Rahimi; John A Spertus; Kimberly J Reid; Susannah M Bernheim; Harlan M Krumholz
Journal:  JAMA       Date:  2007-03-14       Impact factor: 56.272

5.  Younger stroke survivors have reduced access to physician care and medications: National Health Interview Survey from years 1998 to 2002.

Authors:  Deborah A Levine; Catarina I Kiefe; Thomas K Houston; Jeroan J Allison; Ellen P McCarthy; John Z Ayanian
Journal:  Arch Neurol       Date:  2006-11-13

6.  Changes in financial burdens for health care: national estimates for the population younger than 65 years, 1996 to 2003.

Authors:  Jessica S Banthin; Didem M Bernard
Journal:  JAMA       Date:  2006-12-13       Impact factor: 56.272

7.  Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction.

Authors:  Tomas Jernberg; Per Johanson; Claes Held; Bodil Svennblad; Johan Lindbäck; Lars Wallentin
Journal:  JAMA       Date:  2011-04-27       Impact factor: 56.272

8.  Discontinuation of statin therapy and clinical outcome after ischemic stroke.

Authors:  Furio Colivicchi; Andrea Bassi; Massimo Santini; Carlo Caltagirone
Journal:  Stroke       Date:  2007-08-30       Impact factor: 7.914

9.  The effect of the Medicare Part D prescription benefit on drug utilization and expenditures.

Authors:  Wesley Yin; Anirban Basu; James X Zhang; Atonu Rabbani; David O Meltzer; G Caleb Alexander
Journal:  Ann Intern Med       Date:  2008-01-07       Impact factor: 25.391

Review 10.  Medication adherence: its importance in cardiovascular outcomes.

Authors:  P Michael Ho; Chris L Bryson; John S Rumsfeld
Journal:  Circulation       Date:  2009-06-16       Impact factor: 29.690

View more
  12 in total

1.  Racial and ethnic disparities in cost-related medication non-adherence among cancer survivors.

Authors:  Minjee Lee; Ramzi G Salloum
Journal:  J Cancer Surviv       Date:  2015-11-30       Impact factor: 4.442

2.  Gender differences in cost-related medication non-adherence among cancer survivors.

Authors:  Minjee Lee; M Mahmud Khan
Journal:  J Cancer Surviv       Date:  2015-09-09       Impact factor: 4.442

3.  Reach Out Churches: A Community-Based Participatory Research Pilot Trial to Assess the Feasibility of a Mobile Health Technology Intervention to Reduce Blood Pressure Among African Americans.

Authors:  Lesli E Skolarus; Joan Cowdery; Mackenzie Dome; Sarah Bailey; Jonggyu Baek; James Brian Byrd; Sarah E Hartley; Staci C Valley; Sima Saberi; Natalie C Wheeler; Mollie McDermott; Rebecca Hughes; Krithika Shanmugasundaram; Lewis B Morgenstern; Devin L Brown
Journal:  Health Promot Pract       Date:  2017-06-05

4.  The association of depression, cognitive impairment without dementia, and dementia with risk of ischemic stroke: a cohort study.

Authors:  Dimitry S Davydow; Deborah A Levine; Kara Zivin; Wayne J Katon; Kenneth M Langa
Journal:  Psychosom Med       Date:  2015 Feb-Mar       Impact factor: 4.312

5.  Association of Medication Nonadherence Among Adult Survivors of Stroke After Implementation of the US Affordable Care Act.

Authors:  Deborah A Levine; James F Burke; Colman F Shannon; Bailey K Reale; Lena M Chen
Journal:  JAMA Neurol       Date:  2018-12-01       Impact factor: 18.302

6.  Racial differences in statin adherence following hospital discharge for ischemic stroke.

Authors:  Karen C Albright; Hong Zhao; Justin Blackburn; Nita A Limdi; T Mark Beasley; George Howard; Vera Bittner; Virginia J Howard; Paul Muntner
Journal:  Neurology       Date:  2017-04-12       Impact factor: 9.910

7.  Yoga and mindfulness as therapeutic interventions for stroke rehabilitation: a systematic review.

Authors:  Asimina Lazaridou; Phaethon Philbrook; Aria A Tzika
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-27       Impact factor: 2.629

Review 8.  How payment scheme affects patients' adherence to medications? A systematic review.

Authors:  Hamiza Aziz; Ernieda Hatah; Mohd Makmor Bakry; Farida Islahudin
Journal:  Patient Prefer Adherence       Date:  2016-05-13       Impact factor: 2.711

9.  Lacunae in noncommunicable disease control program: Need to focus on adherence issues!

Authors:  Tarundeep Singh; Nidhi Bhatnagar; Gopal Singh Moond
Journal:  J Family Med Prim Care       Date:  2017 Jul-Sep

Review 10.  Predictive factors of non-adherence to secondary preventative medication after stroke or transient ischaemic attack: A systematic review and meta-analyses.

Authors:  Sukainah Al AlShaikh; Terry Quinn; William Dunn; Matthew Walters; Jesse Dawson
Journal:  Eur Stroke J       Date:  2016-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.